These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11348451)

  • 1. Expression of insulin-like growth factor I by cultured skin substitutes does not replace the physiologic requirement for insulin in vitro.
    Swope VB; Supp AP; Greenhalgh DG; Warden GD; Boyce ST
    J Invest Dermatol; 2001 May; 116(5):650-7. PubMed ID: 11348451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes.
    Boyce ST; Supp AP; Swope VB; Warden GD
    J Invest Dermatol; 2002 Apr; 118(4):565-72. PubMed ID: 11918700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor.
    Tavakkol A; Varani J; Elder JT; Zouboulis CC
    Arch Dermatol Res; 1999 Dec; 291(12):643-51. PubMed ID: 10651165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium flow rate regulates viability and barrier function of engineered skin substitutes in perfusion culture.
    Kalyanaraman B; Supp DM; Boyce ST
    Tissue Eng Part A; 2008 May; 14(5):583-93. PubMed ID: 18399733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serum-free culture at the air-liquid interface in a human tissue-engineered skin substitute.
    Jean J; Bernard G; Duque-Fernandez A; Auger FA; Pouliot R
    Tissue Eng Part A; 2011 Apr; 17(7-8):877-88. PubMed ID: 21067466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous Keratinocyte Growth Factor Is Not Required for Pigmentation of Skin Substitutes with Three Isogeneic Cell Types.
    Boyce ST; Supp DM; Lloyd CM
    Tissue Eng Part A; 2020 Feb; 26(3-4):214-224. PubMed ID: 31559928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal morphogenesis in an in-vitro model using a fibroblasts-embedded collagen scaffold.
    Huang YC; Wang TW; Sun JS; Lin FH
    J Biomed Sci; 2005 Dec; 12(6):855-67. PubMed ID: 16228295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor.
    Supp DM; Supp AP; Bell SM; Boyce ST
    J Invest Dermatol; 2000 Jan; 114(1):5-13. PubMed ID: 10620108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors.
    Barreca A; De Luca M; Del Monte P; Bondanza S; Damonte G; Cariola G; Di Marco E; Giordano G; Cancedda R; Minuto F
    J Cell Physiol; 1992 May; 151(2):262-8. PubMed ID: 1374070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes.
    Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S
    Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of fibroblasts in regulating epidermal morphogenesis.
    El Ghalbzouri A; Lamme E; Ponec M
    Cell Tissue Res; 2002 Nov; 310(2):189-99. PubMed ID: 12397374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression pattern of keratin 24 in tissue-engineered dermo-epidermal human skin substitutes in an in vivo model.
    Klar AS; Michalak K; Böttcher-Haberzeth S; Reichmann E; Meuli M; Biedermann T
    Pediatr Surg Int; 2018 Feb; 34(2):237-244. PubMed ID: 29039047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice.
    Boyce ST; Supp AP; Harriger MD; Pickens WL; Wickett RR; Hoath SB
    J Invest Dermatol; 1996 Jul; 107(1):82-7. PubMed ID: 8752844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A.
    Supp DM; Bell SM; Morgan JR; Boyce ST
    Wound Repair Regen; 2000; 8(1):26-35. PubMed ID: 10760212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice.
    Supp AP; Wickett RR; Swope VB; Harriger MD; Hoath SB; Boyce ST
    Wound Repair Regen; 1999; 7(4):226-37. PubMed ID: 10781214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocytes suppress transforming growth factor-beta1 expression by fibroblasts in cultured skin substitutes.
    Le Poole IC; Boyce ST
    Br J Dermatol; 1999 Mar; 140(3):409-16. PubMed ID: 10233258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization.
    Batch JA; Mercuri FA; Edmondson SR; Werther GA
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1444-9. PubMed ID: 7525637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of cultured skin for transplantation using insulin-like growth factor I in conjunction with insulin-like growth factor binding protein 5, epidermal growth factor, and vitronectin.
    Dawson RA; Upton Z; Malda J; Harkin DG
    Transplantation; 2006 Jun; 81(12):1668-76. PubMed ID: 16794533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of vascular endothelial growth factor by fibrin as a dermal substrate for cultured skin substitute.
    Hojo M; Inokuchi S; Kidokoro M; Fukuyama N; Tanaka E; Tsuji C; Miyasaka M; Tanino R; Nakazawa H
    Plast Reconstr Surg; 2003 Apr; 111(5):1638-45. PubMed ID: 12655209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT.
    Edmondson SR; Werther GA; Wraight CJ
    J Invest Dermatol; 2001 Apr; 116(4):491-7. PubMed ID: 11286613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.